In 2000, biologist Steven Austad made a bold prediction that the first person to live to 150 years old was likely alive at that time. Nearly three decades later, advances in aging research have fueled optimism about extending human health span, though whether such longevity is achievable remains a subject of debate within the scientific community.

Aging results from the progressive accumulation of damage in the body’s cells and tissues, which eventually outpaces the body's ability to repair itself. Scientists have identified approximately a dozen hallmarks of aging, including the shortening of telomeres—the protective caps at the ends of chromosomes—mitochondrial decline, protein damage, DNA repair breakdown, and the accumulation of senescent cells. These senescent cells, sometimes described as “zombie cells,” remain metabolically active but no longer perform their intended functions, potentially contributing to inflammation and diseases such as arthritis, atherosclerosis, and cancer. Stem cell depletion, which impairs tissue regeneration, also plays a significant role in the aging process.

Researchers are exploring ways to intervene in these biological mechanisms to delay or reverse aspects of aging. One promising avenue involves senolytic drugs, designed to selectively eliminate senescent cells in order to reduce their harmful effects. Other strategies focus on epigenetic reprogramming, aiming to reset the biochemical markers that regulate gene expression and restore youthful cellular function. Several existing medications approved by the U.S. Food and Drug Administration are also being investigated for their potential to slow aging through their effects on inflammation and metabolism. For example, three diabetes drugs—metformin, SGLT2 inhibitors, and GLP-1 receptor agonists—are currently under study for their longevity benefits.

Organizations such as XPRIZE Healthspan and the Advanced Research Projects Agency for Health (ARPA-H) are funding research to develop biomarkers and testing protocols for anti-aging therapies. However, despite these scientific advances, the emphasis remains largely on extending health span—the length of time an individual remains healthy—rather than significantly prolonging the maximum human lifespan.

Experts caution that claims of dramatic lifespan extension are difficult to validate. “If somebody says they have something that’s going to make you live 50 years longer, then you have to wait 50 years to find out whether or not it’s actually true,” said epidemiologist S. Jay Olshansky of the University of Illinois Chicago. Aging is a complex process involving multiple interacting systems, making it unlikely that any single breakthrough will halt or reverse it entirely. Colleen Murphy, director of the Lewis-Sigler Institute for Integrative Genomics at Princeton University, noted that even if one aging pathway is addressed, others will still contribute to decline.

Technological advances, such as joint replacements or potential future therapies to replace bones or muscles, may help maintain function in aging bodies. However, organs with limited regenerative capacity, notably the brain, remain a significant challenge. Maintaining cognitive function is crucial, as most people would be reluctant to extend life indefinitely without preserved mental capacity.

Austad himself once wagered $150 with Olshansky on whether a person alive today would reach 150 years of age with full mental faculties; the bet’s outcome will not be settled until 2150. Despite hopes to the contrary, the record for the longest verified human lifespan remains 122 years, held by Jeanne Calment, who died in 1997. No documented cases have surpassed this milestone since, underscoring the current limits of human longevity.